Research and Markets (http://www.researchandmarkets.com/research/l4mr58/urinary) has announced the addition of the "Urinary Incontinence-Pipeline Insights, 2016" report to their offering.
Urinary Incontinence-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Urinary Incontinence. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.
The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Urinary Incontinence.
The report also assesses the Urinary Incontinence therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.
Scope
- The report provides competitive pipeline landscape of Urinary Incontinence
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Urinary Incontinence pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Urinary Incontinence and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type
Key Topics Covered:
- Urinary Incontinence Overview
- Urinary Incontinence Pipeline Therapeutics
- Urinary Incontinence Therapeutics under Development by Companies
- Urinary Incontinence Filed and Phase III Products
- Comparative Analysis
- Urinary Incontinence Phase II Products
- Comparative Analysis
- Urinary Incontinence Phase I and IND Filed Products
- Comparative Analysis
- Urinary Incontinence Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Urinary Incontinence - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Urinary Incontinence - Discontinued Products
- Urinary Incontinence - Dormant Products
- Companies Involved in Therapeutics Development for Urinary Incontinence
For more information visit http://www.researchandmarkets.com/research/l4mr58/urinary
View source version on businesswire.com: http://www.businesswire.com/news/home/20160115005693/en/